ADAM-17 is a poor prognostic indicator for patients with hilar cholangiocarcinoma and is regulated by FoxM1

Age-related macular degeneration phenotypes are associated with increased tumor necrosis-alpha and subretinal immune cells in aged Cxcr5 knockout mice

(2017) Hu Huang et al.   PLoS One

Immunohistochemical study on ADAM33 in sinonasal inverted papillomas and squamous cell carcinomas of the larynx

(2016) Olga Stasikowska-Kanicka et al.   Archives of Medical Science

The ADAMs family of proteases as targets for the treatment of cancer

(2016) Maeve Mullooly et al.   CANCER BIOLOGY & THERAPY

Secretome Signature Identifies ADAM17 as Novel Target for Radiosensitization of Non-Small Cell Lung Cancer

(2016) A. Sharma et al.   CLINICAL CANCER RESEARCH

Sodium thiosulfate attenuates glial-mediated neuroinflammation in degenerative neurological diseases

(2016) Moonhee Lee et al.   Journal of Neuroinflammation

Epidemiology of cholangiocarcinoma

(2015) Annika Bergquist et al.   BEST PRACTICE & RESEARCH IN CLINICAL GASTROENTEROLOGY

ADAM10: a new player in breast cancer progression?

(2015) Maeve Mullooly et al.   BRITISH JOURNAL OF CANCER

Prognostic significance of ADAM17 expression in patients with gastric cancer who underwent curative gastrectomy

(2015) D. Aydin et al.   Clinical & Translational Oncology

The Role of Cytokines in Breast Cancer Development and Progression

(2015) Marcela Esquivel-Velázquez et al.   JOURNAL OF INTERFERON AND CYTOKINE RESEARCH

ADAM28 overexpression regulated via the PI3K/Akt pathway is associated with relapse in de novo adult B-cell acute lymphoblastic leukemia

(2015) Xiao-Hui Zhang et al.   LEUKEMIA RESEARCH

PKM2 regulates neural invasion of and predicts poor prognosis for human hilar cholangiocarcinoma

(2015) Guanzhen Yu et al.   Molecular Cancer

p62 provides dual cytoprotection against oxidative stress in the retinal pigment epithelium

(2014) Lei Wang et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH

Differential expression of ANXA1 in benign human gastrointestinal tissues and cancers

(2014) Yunshu Gao et al.   BMC CANCER

The Effect of Disintegrin-Metalloproteinase ADAM9 in Gastric Cancer Progression

(2014) J. M. Kim et al.   MOLECULAR CANCER THERAPEUTICS

Dihydroartemisinin suppresses glioma proliferation and invasion via inhibition of the ADAM17 pathway

(2014) Junyan Chen et al.   NEUROLOGICAL SCIENCES

Advances in the surgical treatment of hilar cholangiocarcinoma

(2014) Takahiro Tsuchikawa et al.   Expert Review of Gastroenterology & Hepatology

Short-term TNFα shedding is independent of cytoplasmic phosphorylation or furin cleavage of ADAM17

(2013) Jeanette Schwarz et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH

Novel Interactions between FOXM1 and CDC25A Regulate the Cell Cycle

(2012) Con Sullivan et al.   PLoS One

Downregulation of metastasis suppressor 1(MTSS1) is associated with nodal metastasis and poor outcome in Chinese patients with gastric cancer

(2010) Ke Liu et al.   BMC CANCER

Role of ADAMs in Cancer Formation and Progression

(2009) M. J. Duffy et al.   CLINICAL CANCER RESEARCH

Activation of FoxM1 during G2 Requires Cyclin A/Cdk-Dependent Relief of Autorepression by the FoxM1 N-Terminal Domain

(2008) J. Laoukili et al.   MOLECULAR AND CELLULAR BIOLOGY

The ADAM metalloproteinases

(2008) D EDWARDS et al.   MOLECULAR ASPECTS OF MEDICINE

Emerging roles of ADAM and ADAMTS metalloproteinases in cancer

(2007) N. Rocks et al.   BIOCHIMIE